UK markets closed

Compass Therapeutics, Inc. (CMPX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.4799-0.0101 (-0.68%)
As of 02:20PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-40,612
-42,494
-39,225
-82,181
-29,500
Depreciation & amortisation
1,816
1,890
1,904
1,624
2,404
Stock-based compensation
5,491
6,120
5,330
4,029
4,016
Change in working capital
5,377
-2,908
-1,263
6,245
-3,600
Accounts payable
1,893
708
2,515
-194
432
Other working capital
-29,084
-40,648
-34,337
-21,234
-26,909
Other non-cash items
-
-
-
41
-960
Net cash provided by operating activities
-28,149
-40,618
-34,125
-19,666
-26,803
Cash flows from investing activities
Investments in property, plant and equipment
-935
-30
-212
-1,568
-106
Purchases of investments
-155,418
-155,418
-200,119
0
-
Sales/maturities of investments
182,413
182,413
48,955
0
-
Other investing activities
-
-
-
-318
-
Net cash used for investing activities
-105,330
26,965
-151,200
-1,770
38
Cash flows from financing activities
Debt repayment
-3,750
-
0
-9,375
-5,625
Common stock issued
128,272
3,126
76,237
128,267
60,482
Other financing activities
-253
-253
-495
-281
-6,319
Net cash used provided by (used for) financing activities
124,241
2,935
75,757
118,611
48,538
Net change in cash
-9,238
-10,718
-109,568
97,175
21,773
Cash at beginning of period
25,719
34,946
144,514
47,339
25,566
Cash at end of period
16,481
24,228
34,946
144,514
47,339
Free cash flow
Operating cash flow
-28,149
-40,618
-34,125
-19,666
-26,803
Capital expenditure
-935
-30
-212
-1,568
-106
Free cash flow
-29,084
-40,648
-34,337
-21,234
-26,909